Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,336,777
-$68,757 QoQ
Shares Held
9,201
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,222
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aureus Asset Management, LLC holds $14,021,737 across 9 Drug Manufacturers - General names. JNJ ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,359 | $4,028,885 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,201 | $2,336,777 | |
| 3 | AMGN |
Amgen Inc
|
4,987 | $1,805,892 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,833 | $1,520,540 | |
| 6 | NVO |
Novo Nordisk A S
|
27,220 | $1,304,926 | |
| 7 | NVS |
Novartis AG
|
5,586 | $875,437 | |
| 8 | AZN |
Astrazeneca PLC
|
1,105 | $209,530 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,336,777 | 9,201 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,405,534 | 9,841 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,966,403 | 19,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,278,040 | 17,679 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,919,510 | 19,113 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,969,380 | 23,935 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,538,128 | 24,465 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,937,571 | 24,297 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,974,236 | 27,191 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,695,395 | 29,682 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,933,078 | 31,473 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,859,938 | 37,624 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,086,004 | 36,769 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,096,830 | 45,786 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,992,705 | 45,246 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,355,120 | 45,024 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,355,395 | 47,070 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,139,356 | 40,283 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,546,581 | 44,114 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,044,476 | 49,811 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,084,121 | 49,072 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,697,616 | 28,583 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,948,978 | 25,092 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,999,065 | 26,861 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,786,744 | 26,927 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,413,313 | 26,030 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||